Allogeneic Pancreatic Islet Cells: Clinical Trials

6 trials of Allogeneic Pancreatic Islet Cells, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 no longer available, 1 terminated, 1 withdrawn. 4 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Terminated 1, Withdrawn 1
Phase 31Completed 1

Follow Allogeneic Pancreatic Islet Cells: new trials by email Literature Review of Allogeneic Pancreatic Islet Cells trials Research Report on Allogeneic Pancreatic Islet Cells

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
LEA29Y (Belatacept) Emory Edmonton Protocol
Allogeneic Pancreatic Islet Cells, Belatacept, Basiliximab - Type 1 Diabetes Mellitus
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)102008-10-012016-04-07
Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation After Kidney Transplant
Low Molecular Weight Sulfated Dextran, Heparin, Mycophenolate Mofetil - Diabetes Mellitus, Type I
Phase 2WithdrawnNational Institute of Allergy and Infectious Diseases (NIAID)2008-07-012014-06-12
B-Lymphocyte Immunotherapy in Islet Transplantation
Allogeneic Pancreatic Islet Cells, Antithymocyte globulin, Daclizumab - Type 1 Diabetes Mellitus
Phase 2TerminatedNational Institute of Allergy and Infectious Diseases (NIAID)22006-11-012016-03-21
Islet Transplantation in Type 1 Diabetes
Allogeneic Pancreatic Islet Cells, Antithymocyte Globulin, Sirolimus - Type 1 Diabetes Mellitus
Phase 3CompletedNational Institute of Allergy and Infectious Diseases (NIAID)482006-10-012019-07-17
Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes
Allogeneic Pancreatic Islet Cells, Deoxyspergualin, Antithymocyte globulin - Diabetes Mellitus, Type 1
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)142006-10-012016-03-16
B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure
Allogeneic Pancreatic Islet Cells, Sirolimus, Basiliximab - Type 1 Diabetes Mellitus
No longer availableNational Institute of Allergy and Infectious Diseases (NIAID)2014-06-11

Conditions studied

Diabetes Mellitus, Type 1 (6)  ·  Hypoglycemia (5)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (6)

Countries

United States (5)  ·  Canada (2)

Top investigators

Andrew Posselt, MD, PhD (2)  ·  Bernhard Hering, MD (2)  ·  Nicole Turgeon, MD (2)  ·  Xunrong Luo, MD, PhD (2)  ·  A.M. James Shapiro, MD, PhD (1)  ·  Ali Naji, MD, PhD (1)  ·  Ali Naji, PhD (1)  ·  Camillo Ricordi, MD (1)  ·  James Shapiro, MD, PhD (1)  ·  Olle Korsgren, MD (1)  ·  Olle Korsgren, PhD (1)

Results publications

PMID 23438305, PMID 23630300, PMID 25629445, PMID 27208344, PMID 27465220, PMID 29563196